BiofilmX

Natural health product licensed in Canada

Licence holder: Vita Aid Professional Therapeutics
NPN or DIN-HM: 80125236
Status: Active licence
Licence date: 27 June 2023
Revision date: 8 May 2025
Form: Capsule, libération retardée
Route of administration: Orale
Application type: Générale (non traditionelle)

If this product were sold in France

À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier	25 FCC GU	Not calculated
1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier	27.7 mg	Not calculated
1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier	10 mg	Not calculated
Protéase fongique Source : Aspergillus flavus var. oryzae - En entier	30 mg	Not calculated
Pectin pectylhydrolase Source : Aspergillus niger - En entier	14.3 mg	Not calculated
Nattokinase Source : Bacillus subtilis var. natto - Whole	70 mg	Not calculated
Nattokinase Source : Bacillus subtilis var. natto - Whole	1,400 FU	Not calculated
Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière	30,000 SPU	Not calculated
1,3-bêta-D-Xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier	1,100 XAU	Not calculated
1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier	30 FCC BGU	Not calculated
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier	500 FCC CU	Not calculated
Protéase fongique Source : Aspergillus flavus var. oryzae - En entier	15,000 FCC HUT	Not calculated
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier	10 mg	Not calculated

Non-medicinal ingredients

Palmitate d'ascorbyle, L-Leucine, Pullulane, Cellulose microcristalline, Dioxyde de silicium, Maltodextrine, Hypromellose

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Capsule	2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.